Institutional Biosafety Committee for Human Subjects

Vanderbilt Human Research Protection Program
Institutional Biosafety Committee-Human Subjects
NIH Registration Number TN00040

 

The IBC-HS Committee meets the third Friday of the month from 8:30 to 10:30 am. Meeting locations are subject to change. Please call the VHRPP office to confirm meeting location (322-2918).

Effective – July 22, 2022

VOTING MEMBERS (10)

Antonios Hatzopoulos, PhD - Chair

Allison Wheeler, M.D., MSCI - Vice Chair

Richard DiTullio, PhD

Rolinda Bailey, BSMT(ASCP)

Cary Fu, M.D.

Douglas Johnson, M.D., MSCI

Ana Nobis, MD, MPH, FACOEM

Donna Torr, PharmD

Kimberly Towers, BS

Vacancy

Cell & Developmental Biology

Hematology/Oncology

Biological Safety

Safety Officer TN DOH, Community Member

Neurology, Pediatric

Hematology/Oncology

Occupational Health

Pharmacy

Law Enforcement, Community Member

 

Vanderbilt’s Institutional Biosafety Committee-Human Subjects (IBC-HS) is authorized by the National Institutes of Health (NIH) to approve research projects involving the use of recombinant DNA and synthetic nucleotide research involving humans. Use the IBC application that is embedded in the IRB application and guidelines to submit proposals to the IBC-HS. If you need help in completing and IBC-HS application, contact the IRB to have the a member of the IBC-HS team to assist you.

  • Jennifer Bounds - Homemaker, Community Member
    Brenton Harrison, BBA - Business, Community Member
    Carrie Kitko, M.D. - Hematology/Oncology, Pediatric
    Meryk Moore, PharmD - Pharmacy
    Ray Peebles, M.D. - Pathology, Microbiology and Immunology